SMILAX LABORATORIES LIMITED

SMILAX LABORATORIES LIMITED is a manufacturer.

SMILAX LABORATORIES LIMITED is an India-based pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Established in 1997, the company has grown to become a significant player in the pharmaceutical sector, known for its focus on quality, research, and development. They operate modern manufacturing facilities that comply with international regulatory standards, including those of the USFDA and EDQM. Smilax Laboratories caters to both domestic and international markets, supplying critical pharmaceutical ingredients for various therapeutic areas. Their commitment to innovation and stringent quality control makes them a reliable partner in the global pharmaceutical supply chain.

Smilax Laboratories Limited, an Indian company, primarily manufactures and sells Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Their product portfolio includes:

Proton Pump Inhibitors (PPIs):

Pantoprazole Sodium

Rabeprazole Sodium

Esomeprazole Magnesium

Omeprazole

Lansoprazole

Antidiabetics:

Dapagliflozin

Empagliflozin

Sitagliptin Phosphate

Vildagliptin

Metformin Hydrochloride

Antipsychotics:

Aripiprazole

Olanzapine

Quetiapine Fumarate

Risperidone

Cardiovascular Agents:

Atorvastatin Calcium

Rosuvastatin Calcium

Telmisartan

Valsartan

Amlodipine Besylate

Gastroprokinetics:

Itopride Hydrochloride

Domperidone

Neuropathic Pain and CNS Agents:

Gabapentin

Pregabalin

Baclofen

Erectile Dysfunction Drugs:

Sildenafil Citrate

Tadalafil

Other APIs:

Clopidogrel Bisulphate

Finasteride

Dutasteride